| Stephanie Lynn Osborne, PHARMD, CPH | |
|
9655 Boynton Beach Blvd, Boynton Beach, FL 33472-4421 | |
| (561) 336-7047 | |
| Not Available |
| Full Name | Stephanie Lynn Osborne |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 9655 Boynton Beach Blvd, Boynton Beach, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033706635 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PS49910 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Lynn Osborne, PHARMD, CPH 9004 Willow Sound Dr, Lake Worth, FL 33467-1191 Ph: (561) 704-1385 | Stephanie Lynn Osborne, PHARMD, CPH 9655 Boynton Beach Blvd, Boynton Beach, FL 33472-4421 Ph: (561) 336-7047 |
News Archive
Chemicals called polybrominated diphenyl ethers (PBDEs) have been used for decades to reduce fires in everyday products such as baby strollers, carpeting and electronics. A new study to be presented on Monday, May 6, at the Pediatric Academic Societies (PAS) annual meeting shows that prenatal exposure to the flame retardants is associated with lower intelligence and hyperactivity in early childhood.
The New York Times reports that "recent reports of women being coerced into late-term abortions by local officials have thrust China's population control policy into the spotlight and ignited an outcry among policy advisers and scholars who are seeking to push central officials to fundamentally change or repeal a law that penalizes families for having more than one child."
Throughout the spread of the virus, genomic sequencing has played a role in epidemiologic tracking of the viral strains carried all over the world. Such strains are traced back to their origin by their unique mutations and help to link remote infections.
Neurotech SA announced positive results from an open-label Phase I clinical trial (03-EI-0234) of its lead product, NT-501. NT-501 uses Neurotech's patented Encapsulated Cell Technology (ECT) as a device to deliver ciliary neurotrophic factor (CNTF) to eyes of visually impaired patients with retinitis pigmentosa (RP). Neurotech is a biotechnology company specializing in the development of novel therapeutics to treat diseases of the eye. The company is headquartered in Paris.
› Verified 7 days ago
Tamara Cook, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3200 Old Boynton Rd, Boynton Beach, FL 33436 Phone: 561-742-4055 | |
Miruna Campbell, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9824 S Military Trl, Boynton Beach, FL 33436 Phone: 561-732-9115 Fax: 561-732-5216 | |
Dr. Farzad Tafazzoli, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 650 N Congress Ave, Boynton Beach, FL 33426 Phone: 561-396-2203 | |
Howard Jendlin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11079 S Military Trl, Boynton Beach, FL 33436 Phone: 561-736-2998 Fax: 561-734-7253 | |
Yelena Buslova, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12750 S Military Trl, Boynton Beach, FL 33436 Phone: 561-637-3695 Fax: 561-637-7354 | |
Gidnie Metayer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12425 Hagen Ranch Rd, Boynton Beach, FL 33437 Phone: 561-292-4494 Fax: 561-292-4499 |